Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 7
1984 11
1985 22
1986 43
1987 90
1988 84
1989 102
1990 99
1991 87
1992 92
1993 88
1994 114
1995 97
1996 73
1997 56
1998 75
1999 66
2000 56
2001 45
2002 62
2003 55
2004 49
2005 82
2006 59
2007 62
2008 66
2009 58
2010 59
2011 56
2012 66
2013 60
2014 67
2015 67
2016 39
2017 49
2018 44
2019 42
2020 75
2021 99
2022 72
2023 72
2024 77
2025 41
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,614 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of famotidine.
Echizen H, Ishizaki T. Echizen H, et al. Clin Pharmacokinet. 1991 Sep;21(3):178-94. doi: 10.2165/00003088-199121030-00003. Clin Pharmacokinet. 1991. PMID: 1764869 Review.
Famotidine is a potent histamine H2-receptor antagonist widely used in the treatment and prevention of peptic ulcer disease. ...Coadministration of potent antacids reduces the oral absorption of famotidine by 20 to 30%. On a weight-to-weight basis, the antisecretory …
Famotidine is a potent histamine H2-receptor antagonist widely used in the treatment and prevention of peptic ulcer disease. ...Coadm …
Therapeutic Status of Famotidine in COVID-19 Patients: A Review.
Mohseni M, Raissi V, Sharifan Y, Barikro K, Amiri S, Mohseni MS, Raeisi F, Masoumi K, Khodakarami S, Raiesi O. Mohseni M, et al. Infect Disord Drug Targets. 2022;22(3):e070122200096. doi: 10.2174/1871526522666220107125511. Infect Disord Drug Targets. 2022. PMID: 34994318 Review.
Early clinical evidence from many sources suggests that treatment with famotidine may decrease COVID-19-related morbidity and mortality. The mechanism by which famotidine could improve the outcomes of COVID-19 is currently unknown. A more recent postulated mechanism …
Early clinical evidence from many sources suggests that treatment with famotidine may decrease COVID-19-related morbidity and mortali …
Probable famotidine-induced thrombocytopenia.
Zimmermann AE, Katona BG, Hrehorovich VR. Zimmermann AE, et al. DICP. 1991 Jun;25(6):678. doi: 10.1177/106002809102500622. DICP. 1991. PMID: 1877281 No abstract available.
Famotidine-associated mental status changes.
Rodgers PT, Brengel GR. Rodgers PT, et al. Pharmacotherapy. 1998 Mar-Apr;18(2):404-7. Pharmacotherapy. 1998. PMID: 9545163
Case reports of central nervous system effects with other histamine2 antagonists have been published. Eight cases occurred with famotidine, all of which were in hospitalized patients receiving intravenous famotidine. We believe this is the first report of mental sta …
Case reports of central nervous system effects with other histamine2 antagonists have been published. Eight cases occurred with famotidin …
Famotidine in gastroesophageal reflux disease (GERD).
Wesdorp IC. Wesdorp IC. Hepatogastroenterology. 1992 Feb;39 Suppl 1:24-6. Hepatogastroenterology. 1992. PMID: 1577391 Review.
Famotidine, a potent and long-acting H2-receptor antagonist, has been evaluated in patients with gastroesophageal reflux disease (GERD). ...Famotidine is a very useful H2-receptor antagonist for the treatment of most patients with GERD....
Famotidine, a potent and long-acting H2-receptor antagonist, has been evaluated in patients with gastroesophageal reflux disease (GER …
Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
James LP, Kearns GL. James LP, et al. Clin Pharmacokinet. 1996 Aug;31(2):103-10. doi: 10.2165/00003088-199631020-00002. Clin Pharmacokinet. 1996. PMID: 8853932 Review.
Famotidine, an H2 receptor antagonist, has several potential advantages over cimetidine and ranitidine. ...These data support a starting paediatric dosage for intravenous famotidine of 0.5 mg/kg every 8 to 12 hours. In addition, the safety and efficacy of famotid …
Famotidine, an H2 receptor antagonist, has several potential advantages over cimetidine and ranitidine. ...These data support a start …
The tolerability and safety profile of famotidine.
Howden CW, Tytgat GN. Howden CW, et al. Clin Ther. 1996 Jan-Feb;18(1):36-54; discussion 35. doi: 10.1016/s0149-2918(96)80177-9. Clin Ther. 1996. PMID: 8851452 Review.
Since its introduction for the treatment of acid-related disorders in 1985, an estimated 18.8 million patients worldwide have been treated with famotidine. We present a comprehensive safety profile of oral famotidine, incorporating data from investigational trials, …
Since its introduction for the treatment of acid-related disorders in 1985, an estimated 18.8 million patients worldwide have been treated w …
Neuroprotective Effect of Famotidine in Mouse Models of Alzheimer's Disease.
Sadiq MH, Al-Zubaidy AA. Sadiq MH, et al. Clin Lab. 2024 Aug 1;70(8). doi: 10.7754/Clin.Lab.2024.240147. Clin Lab. 2024. PMID: 39193965
BACKGROUND: Famotidine is a competitive histamine H-receptor antagonist that reduces the formation of stomach acid and is used to treat gastrointestinal disorders associated with acid reflux, gastroesophageal reflux disease, duodenal ulcer, gastric ulcer, and pathological …
BACKGROUND: Famotidine is a competitive histamine H-receptor antagonist that reduces the formation of stomach acid and is used to tre …
Famotidine in the management of schizophrenia.
Martinez MC. Martinez MC. Ann Pharmacother. 1999 Jun;33(6):742-7. doi: 10.1345/aph.18262. Ann Pharmacother. 1999. PMID: 10410190 Review.
Key search terms included famotidine, schizophrenia, and histamine. DATA SYNTHESIS: Schizophrenia is a complicated disorder associated with high morbidity if left unmanaged. ...An evaluation of studies focusing on famotidine in the management of schizophrenic sympto …
Key search terms included famotidine, schizophrenia, and histamine. DATA SYNTHESIS: Schizophrenia is a complicated disorder associate …
2,614 results